The investigating the molecular mechanisms of cognitive impairment due to cancer chemotherapy and its prevention
The investigating the molecular mechanisms of cognitive impairment due to cancer chemotherapy and its prevention
批准号:
21591515
负责人:
TANIMUKAI Hitoshi
金额:
$2.91万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2009
资助国家:
日本
项目状态:
已结题
起止时间:
2009 至 2011
中文摘要
为探讨化疗所致认知功能障碍的分子机制,我们研究了紫杉醇(PX)、氟尿嘧啶(5-FU)和环磷酰胺(CPA)对培养的神经细胞(SY5Y和SK-N-SH)的神经毒性作用,并进一步探讨了其与内质网应激(ER应激)的关系。在PX和5-FU处理的细胞中可观察到显著的NT,且呈剂量依赖关系,而CPA处理的细胞则无明显变化。另外,PX或5-FU均能诱导p-eIF2α和GRP78/94在细胞中的表达。用Bip诱导剂X(Bix)预先处理细胞可减少PX诱导的NT,但不能减少5-FU诱导的NT。提示Px诱导的NT可能与内质网应激有关,Bix可阻止Px诱导的NT包括化学损伤。
英文摘要
To investigate the molecular mechanisms of chemotherapy induced cognitive impairment, we studied the neuronal toxicity(NT) of paclitaxel(Px), fluorouracil(5-FU), and cyclophosphamide(CPA) on neuronal culture cells(SY5Y and SK-N-SH) and further investigated its relationship to endoplasmic reticulum stress(ER stress). Significant NT was observed in cells treated with Px and 5-FU in dose dependent manner, but not with CPA. In addition, the induction of both p-eIF2αand GRP78/ 94 were observed in cells by Px or 5-FU treatment. Pre-treatment of cells with Bip inducer X(BIX) reduced Px-induced NT but not 5-FU induced NT. These data suggest that Px induced NT probably relates to ER stress and BIX could prevent the Px induced NT as including chemobrain.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
看護学テキストNiCE『疾患と治療III』「せん妄」
护理教材NiCE《疾病与治疗III》《谵妄》
DOI:
--
发表时间:
2010
期刊:
影响因子:
--
作者:
[数井裕光, 武田雅俊, 谷向仁(分担執筆)]
通讯作者:
谷向仁(分担執筆)
血液がん患者における不眠の実態及び抑うつとの関連に関する研究
血癌患者失眠的现实及其与抑郁的关系研究
DOI:
--
发表时间:
2011
期刊:
影响因子:
--
作者:
[谷向仁, 平井啓, 足立浩祥]
通讯作者:
足立浩祥
Can "Steroid Switching" Improve Steroid-Induced Musical Hallucinations in a Patient with Terminal Cancer?
“类固醇转换”能否改善晚期癌症患者类固醇引起的音乐幻觉?
DOI:
--
发表时间:
2010
期刊:
Journal of Palliative Medicine
影响因子:
2.8
作者:
[Kanemura S, Tanimukai H, Tsuneto S]
通讯作者:
Tsuneto S
がん患者にみられる様々な認知機能障害~せん妄を中心に~
癌症患者中出现的各种认知功能障碍 - 关注谵妄 -
DOI:
--
发表时间:
2010
期刊:
影响因子:
--
作者:
[杉山博通, 数井裕光, 武田雅俊, 谷向仁]
通讯作者:
谷向仁
Can milnacipran used for neuropathic pain in patients with advanced cancer causeneuromuscular and somatosensory disorders?
米那普仑用于治疗晚期癌症患者的神经性疼痛会导致神经肌肉和躯体感觉障碍吗?
DOI:
--
发表时间:
2011
期刊:
J Palliat Med
影响因子:
2.8
作者:
[Nakagawa S, Okamoto Y, Tsuneto S, Tanimukai H, Goya S, Matsuda Y, Oono Y, Tsugane M, Uejima E]
通讯作者:
Uejima E
共 24 条
A study on new delirium pharmacotherapy based on symptom-biomarker-pharmacological profile
-
批准号:17K10298
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.0万
-
财政年份:2017
-
负责人:TANIMUKAI Hitoshi
-
依托单位:
海外基金